The perfect pair: growth and opportunity in emerging markets

Emerging markets represent an undeniable opportunity for innovation in medicine as growth continues to outstrip that of developed markets, says Andrew Lane, executive vice president of Abbott’s pharmaceutical business.

In the first half of 2018, global equity markets experienced volatility. But, emerging markets, such as India and China, displayed a healthy resilience, even outperforming their developed counterparts.

Moving forward, developing economies are expected to grow even further – the International Monetary Fund estimates 4.9% GDP growth for emerging markets in 2018, up from 4.7% in 2017.